User profiles for "author:N. Bhala"

Neeraj Bhala

University of Nottingham
Verified email at nottingham.ac.uk
Cited by 98230

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a …

…, H Benzian, E Bernabe, TJ Beyene, N Bhala… - The lancet, 2015 - thelancet.com
Background Up-to-date evidence about levels and trends in disease and injury incidence,
prevalence, and years lived with disability (YLDs) is an essential input into global, regional …

[HTML][HTML] Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis

…, N Peleg, A Shlomai, G Sebastiani, Y Seko, N Bhala… - Gastroenterology, 2020 - Elsevier
Background & Aims Biopsy-confirmed liver fibrosis is a prognostic factor for patients with
nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the …

Five insights from the global burden of disease study 2019

…, K Berhe, AE Berman, AS Bhagavathula, N Bhala… - The Lancet, 2020 - thelancet.com
Summary The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019
provides a rules-based synthesis of the available evidence on levels and trends in health …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017 …

…, RS Bernstein, M Beuran, T Beyranvand, N Bhala… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and …

[HTML][HTML] Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

…, E Bernabe, GJ Bertolacci, R Bhageerathy, N Bhala… - The lancet, 2020 - thelancet.com
Background In an era of shifting global agendas and expanded emphasis on non-
communicable diseases and injuries along with communicable diseases, sound evidence …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the …

…, E Bernabé, BD Betsu, AS Beyene, N Bhala… - The lancet, 2016 - thelancet.com
Background Non-fatal outcomes of disease and injury increasingly detract from the ability of
the world's population to live in full health, a trend largely attributable to an epidemiological …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic …

…, E Bernabé, BD Betsu, M Beuran, AS Beyene, N Bhala… - The Lancet, 2017 - thelancet.com
Background As mortality rates decline, life expectancy increases, and populations age, non-
fatal outcomes of diseases and injuries are becoming a larger component of the global …

[HTML][HTML] Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990 …

…, E Bernabé, BD Betsu, AS Beyene, N Bhala… - The lancet, 2016 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the …

[HTML][HTML] Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 …

…, RS Bernstein, M Beuran, T Beyranvand, N Bhala… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
(GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor …

[HTML][HTML] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials

…, J Emberson, LE Holland, C Reith, N Bhala… - The Lancet, 2010 - diva-portal.org
Background Lowering of LDL cholesterol with standard statin regimens reduces the risk of
occlusive vascular events in a wide range of individuals. We aimed to assess the safety and …